Paper3698035
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
von Roenn JH and 3 others. Cancer Res, 1986. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Papers, record 3698035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3698035
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aneuploidy | Major topic |
| DNA, Neoplasm | Major topic |
| Flow Cytometry | Major topic |
| Melanoma | Major topic |
| Nevus, Pigmented | Major topic |
| Skin Neoplasms | Major topic |
| Follow-Up Studies | |
| Humans | |
| Prognosis | |
| Retrospective Studies | |
| Skin Ulcer |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36276131 | Causes, consequences and clinical significance of aneuploidy across melanoma subtypes. | Front Oncol | 2022 | https://conductscience.org/library/papers/36276131 | PubMed |
| 9667668 | Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9667668 | PubMed |
| 8304780 | Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former. | Arch Dermatol Res | 1993 | https://conductscience.org/library/papers/8304780 | PubMed |
| 8129491 | Surgical management and prognostic factors in patients with subungual melanoma. | Ann Surg | 1994 | https://conductscience.org/library/papers/8129491 | PubMed |
| 7626566 | DNA index and S phase fraction in uveal malignant melanomas. | Br J Ophthalmol | 1995 | https://conductscience.org/library/papers/7626566 | PubMed |
| 3355269 | Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. | Ann Surg | 1988 | https://conductscience.org/library/papers/3355269 | PubMed |
| 3219270 | The flow cytometry of melanocytic skin lesions. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3219270 | PubMed |
| 3192729 | DNA content and MHC class II antigen expression in malignant melanoma: clinical course. | J Clin Pathol | 1988 | https://conductscience.org/library/papers/3192729 | PubMed |
| 1911224 | DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1911224 | PubMed |
| 1520590 | Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1520590 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3698035
GET https://conductscience.org/api/papers/v1/3698035/authors